voruciclib

Ligand id: 9923

Name: voruciclib

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 3
Hydrogen bond donors 3
Rotatable bonds 4
Topological polar surface area 94.14
Molecular weight 469.09
XLogP 4.88
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

Classification
Compound class Synthetic organic
IUPAC Name
2-[2-chloro-4-(trifluoromethyl)phenyl]-5,7-dihydroxy-8-[(2R,3S)-2-(hydroxymethyl)-1-methylpyrrolidin-3-yl]chromen-4-one
International Nonproprietary Names
INN number INN
9791 voruciclib
Synonyms
P1446A | P1446A-05
Comments
Voruciclib (P1446A, or P1446A-05) is an orally active, non-selective CDK inhibitor that was developed for antineoplastic potential. Potent inhibition of CDK9, 4/6 and 1 by voruciclib is considered as a novel pro-apoptotic mechanism applicable to the treatment of malignant melanoma [3] and to overcome resistance to Bcl-2 inhibition (e.g. by venetoclax) in B cell malignancies [2,4].
Use of voruciclib in combination with BRAF inhibitors for the treatment of malignant melanoma is claimed in patent US20160136132A1 [1]. Preparation of pure (+)-trans enantiomer of the compound shown here, is claimed in patent WO2007148158A1 [5].
Database Links
CAS Registry No. 1000023-04-0 (source: WHO INN record)
GtoPdb PubChem SID 363894217
PubChem CID 67409219
Search Google for chemical match using the InChIKey MRPGRAKIAJJGMM-OCCSQVGLSA-N
Search Google for chemicals with the same backbone MRPGRAKIAJJGMM
Search PubMed clinical trials voruciclib
Search PubMed titles voruciclib
Search PubMed titles/abstracts voruciclib
Search UniChem for chemical match using the InChIKey MRPGRAKIAJJGMM-OCCSQVGLSA-N
Search UniChem for chemicals with the same backbone MRPGRAKIAJJGMM